Tirzepatide
Overview
Tirzepatide is a synthetic dual GIP and GLP-1 receptor agonist studied for its effects on glucose metabolism and metabolic regulation. Each vial contains 10 mg of lyophilized powder, 99%+ purity. For research use only.
Product Details
| Product | Tirzepatide 10 mg and 60 mg |
|---|---|
| Category | Peptides |
| Listed price | $50.00 – $150.00 |
Research Information
Research Information: Tirzepatide, a GIP/GLP-1 agonist, has a half-life of ~5 days. Weight: 4,813.5 Da Overview First-in-class dual GIP and GLP-1 receptor agonist. Combines two incretin pathways for synergistic metabolic effects beyond single-agonist approaches. Available as 10 mg lyophilized powder at 99%+ purity. Mechanism of Action Co-activates GIP and GLP-1 receptors, producing additive effects on insulin secretion, glucagon suppression, gastric emptying delay, and appetite reduction. GIP receptor activity may enhance β-cell function and fat metabolism. This information is provided for research and educational purposes only. This product is not intended for human use, diagnosis, treatment, or prevention of any medical condition. For research use only.
Further Information
Research-use notice: For research and educational purposes only. Not intended for human or veterinary use, diagnosis, treatment, cure, or prevention of any disease. Do not present this product as an approved medicine.




Reviews
There are no reviews yet.